It inhibits the proliferation and diffusion of many tumors, regulates the autophagy in chronic myelogenous leukemia, and reduces the epithelial-mesenchymal transition induced by TGF-β1 [20]. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.